ArticleBMC cancer2016

Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition.

McKale R Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.